Company Filing History:
Years Active: 2025
Title: Adam Shapiro: Innovator in Microbial Dysbiosis Management
Introduction
Adam Shapiro is a notable inventor based in Wellesley, MA (US). He has made significant contributions to the field of microbiology, particularly in managing microbial dysbiosis. His innovative approach utilizes temocillin to address various intestinal disorders.
Latest Patents
Adam Shapiro holds a patent for "Managing microbial dysbiosis with temocillin." This patent outlines methods for using temocillin to control microbial dysbiosis, particularly arising from enterobacteriaceae overgrowth. The methods described also include treating intestinal disorders and symptoms caused by microbial dysbiosis.
Career Highlights
Adam is currently associated with Entasis Therapeutics, Inc., where he continues to develop and refine his innovative methods. His work focuses on improving health outcomes through targeted microbial management.
Collaborations
Some of his notable coworkers include Ramkumar Iyer and Samir Moussa, who contribute to the collaborative efforts at Entasis Therapeutics, Inc.
Conclusion
Adam Shapiro's work in managing microbial dysbiosis represents a significant advancement in the field of microbiology. His innovative use of temocillin has the potential to improve treatment options for various intestinal disorders.